PBYI Key Stats
- Biggest Winners in Biotech This Year Fool 10:41 AM
- Puma Biotechnology (PBYI) Jumps: Stock Up 11.7% - Tale of the Tape Zacks 9:39 AM
- This Week in Biotech: Part 2 Fool Dec 7
- 3 Humongous Health-Care Stocks This Week Fool Dec 7
- Why Diamond Foods, Puma Biotechnology, and Vaalco Energy Soared Today Fool Dec 6
- PBYI Soars on Positive Neratinib Data - Analyst Blog Zacks Dec 6
- PBYI Soars on Positive Neratinib Data Dec 6
- Why Puma Biotechnology, Methode Electronics, and Conn's Are Today's 3 Best Stocks Fool Dec 5
- Why Puma Biotechnology Inc. Shares Skyrocketed Fool Dec 5
- Unusual 11 Mid-Day Movers 12/05: (CALI) (PBYI) (MEI) Higher; (SOL) (WTSL) (NWY) lower Street Insider Dec 5
PBYI Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Puma Biotechnology is up 351.7% over the last year vs S&P 500 Total Return up 30.64%, Actelion up 64.18%, and Roche Holding up 43.31%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Balance Sheet View Statement
Pro Ratings for PBYI
Pro Report PDF for PBYI
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download PBYI Pro Report PDF
Pro Strategies Featuring PBYI
Did Puma Biotechnology make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
Puma Biotechnology Inc is a development-stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer.